The global VR stroke rehabilitation market enjoys a valuation of US$ 144.9 Billion in 2022, and it is further projected to expand at a CAGR of 9.2% over the forecasted years. According to a recent study by Future Market Insights, long term patients are leading the market with a share of about 69.2% in the year 2022, within the global market.
Market Outlook
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 144.9 Billion |
| Market Value 2033 | US$ 376.0 Billion |
| CAGR 2023 to 2033 | 9.2% |
| Market Share of Top 5 Countries | 64.1% |
A program called stroke rehabilitation is made up of a variety of therapies that help the patient regain lost cognitive and motor skills following a stroke. Rehabilitation can assist the patient with movement, speech, strength, and daily living skills, depending on the part of the brain affected by the stroke.
VR systems take into account a number of motor learning and neuroscience hypotheses. Virtual reality (VR) games enable repetitive, task-focused practice with intense yet adjustable difficulty to support an ideal practice routine. A VR teacher option is also available in some VR games, providing the opportunity for "learning by imitation" through activating mirror neurons. The VR system also offers the use of augmented performance feedback that is given concurrently with performance, right after a performance based on outcomes (knowledge of results), or after numerous trials as summary feedback.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global sales of the market are anticipated to rise at a CAGR of 9.2% between 2023 and 2033, owing to the rising prevalence of various brain injury.
The global VR stroke rehabilitation market holds around 50.5% share of the overall global stroke rehabilitation market with a value of around US$ 286.7 Billion, in 2022.
For stroke victims, virtual reality (VR) technology has the potential to offer a more immersive and interesting rehabilitation experience, which may result in better outcomes and a quicker recovery.
The global rise in stroke prevalence is a further significant issue. The Global Stroke Organization estimates that 17 million individuals worldwide experience a stroke each year, making it the second greatest cause of mortality worldwide. As a result, there is an increasing need for effective and cutting-edge rehabilitation solutions such as NuStep T5, omniCycle Elite, etc.
Looking at the previous ten years, the market for VR-based rehabilitation has expanded dramatically due to advancements in VR technology and growing public awareness of the potential advantages of VR in healthcare. Yet, the business is still developing and has a lot of ability to grow as more healthcare.
The market for virtual reality (VR) stroke rehabilitation is anticipated to expand significantly over the next few years, as the prevalence of stroke cases is rising globally, and patients are increasingly favouring non-invasive and interesting therapy choices. The creation of more immersive and interactive rehabilitation programmes that can better replicate real-world environments has also been facilitated by improvements in VR technology.
Through the use of virtual reality (VR) technology, stroke patients can participate in activities that imitate real-world situations for partial or comprehensive physical and cognitive therapy. Functional exercises like star-climbing, getting out of a chair, and other motor exercises that assist the patient regain strength and motion in a virtual environment can be included in these activities.
Owing to the above-mentioned factors, the global market is expected to grow at a prominent pace, and reach a valuation of around US$ 376.0 Billion during the year 2033.
Commercial gaming consoles in particular are gaining popularity in hospital settings as a novel therapy option for stroke rehabilitation using virtual reality. Using VR, the stroke patient is treated in a digitally created virtual world, and the data gathered is sent to the specialist for intensive analysis.
Government investments in healthcare infrastructure and rising health spending will also promote the production of pricey pharmaceuticals and medical equipment. Advanced medical equipment will be used more frequently in hospitals, ambulatory surgery centres, primary healthcare facilities, etc. In emerging regions, there are more healthcare facilities and more infrastructure being built. Hence, it is anticipated that during the coming years, the need for therapy would rise even more. Leading manufacturers have profitable chances to grow their businesses in nations where the frequency of depression and other mental health conditions is sharply rising. This will significantly aid in raising their market share.
One of the benefits of virtual reality is the ability to gamify simulations, which makes it a great tool for cognitive function intervention by making the tasks and procedures of rehabilitation seem more interesting and less routine. VR can be a fantastic supplemental tool to support more conventional cognitive therapy by enhancing perception, orientation, and focus abilities. Users are given the chance to practise tasks and functions that have been broken down into smaller levels while feeling present and focused thanks to immersive simulations. Stronger cognitive connections are created as a result of high visual fidelity, which facilitates simple information perception.
The potential of VR to be used remotely, allowing patients and medical professionals to engage from different locations, is a huge advantage. This makes it possible to continue supervised therapy without needing to be physically present at the medical centre, which can be very useful during prolonged lockdowns.
Principal Consultant
Robotic simulators and other sorts of technical equipment are some of the more expensive rehabilitation treatments and therapies. As technology has improved healthcare, it has also increased costs, making some patients unable to pay for these treatments. Most of the patients come from poor, rural areas. Poor patients are unable to afford costly therapies and equipment. Thus, the market for VR-based stroke therapy may see growth challenges due to the increased costs of such devices and treatments. Rehabilitation is crucial for post-stroke patients to achieve full functional independence while reducing or avoiding deficits. Although mobility is a crucial component of an affected patient's independence and confidence, technology solutions created to date have mostly concentrated on physical recovery in terms of patient function.
By switching from hospital-based care to home-based care, VR-based technology can lower healthcare costs, however the key manufacturers are not putting much effort into the development of such technologies. The market for VR-based stroke rehabilitation may suffer as a result of this.
The treatment of depression patients may suffer as a result of the lack of such trained specialists, and the expansion of the organisations involved in the treatment may also be stunted. These factors may have an adverse effect on service quality, which would ultimately hinder the expansion of the market for VR stroke rehabilitation.
The USA dominates the global market with a total market share of around 38.1% in 2022 and is expected to continue to experience the same growth throughout the forecast period.
The rising incidence of stroke, which is the fifth largest cause of death in the USA, is a significant reason causing this development.
VR based technology can be applied to stroke rehabilitation to help patients with their motor abilities, cognitive function, and general quality of life. In the United States, numerous businesses and organizations are currently creating and offering VR-based stroke rehabilitation solutions. The market for VR-based stroke rehabilitation is anticipated to expand considerably more in the upcoming years as its success rate keeps rising.
Germany holds a market share of 7.8% in 2022 in the global VR stroke rehabilitation market, as virtual reality technology becomes more widely available and neurorehabilitation research advances, the market for VR stroke rehabilitation is expanding globally. Reha-Stim Medtec, which provides a VR therapy system for upper limb rehab, and Ludwig-Maximilians-Universität München, which has researched the efficacy of VR games for improving physical and cognitive function in stroke patients, are just two of the companies and research institutions in Germany working on VR stroke rehabilitation. This technology has the potential to significantly enhance stroke rehabilitation results and offer fresh, cutting-edge treatment modalities.
Germany also has a robust healthcare system that gives innovation and technology a high priority. The nation is investing heavily in VR stroke rehabilitation research and development, which is propelling the market's expansion. The potential advantages of VR therapy are also becoming more widely known among medical professionals and patients, which is encouraging this technology's use in stroke rehabilitation.
India holds a share of around 2.6% in the global market in 2022. The VR stroke therapy industry in India is expanding for a variety of reasons. First and foremost, India's ageing population increases the likelihood of having a stroke, increasing the need for efficient stroke rehabilitation treatments.
The general public and medical experts are also becoming more aware of the advantages of virtual reality-based rehabilitation for stroke patients. Because of this, VR stroke therapy options are being adopted more widely. A significant factor in the expansion of this market in India is the emergence of technical developments in the healthcare sector. Also, the number of businesses is investing in VR technology specifically for stroke rehabilitation, which is predicted to sustain market growth over the next few years.
China has a market share of 6.1% share in the global VR stroke rehabilitation market in 2022.
The VR stroke therapy market in China is expanding for a variety of reasons. Due to variables including quickly evolving modern lifestyles, an ageing population, and high levels of stress, the prevalence of stroke is rising in China. Effective rehabilitation solutions for stroke victims are now necessary as a result of this.
VR technology has shown to be a useful tool for stroke therapy, and there is a rising need for cutting-edge rehabilitation solutions in China. Patients can practice movements and exercises in a safe and regulated setting, and it can also offer more unique and interesting rehabilitation experiences.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The long-term patients type holds 69.2% share of the global market. The VR stroke rehabilitation market may increase significantly with the help of long-term patients. VR therapy sessions can be participatory and entertaining for stroke victims, which can improve patient compliance and quick healing.
Long-term users can also contribute to the development and improvement of the technology by offering insightful input that can be used to enhance the effectiveness and efficiency of VR stroke therapy programs. Long-term users are likely to be a crucial and significant component of the market's development and expansion as VR technology develops.
Rehabilitation Centers hold a market share of 36.6% during the year 2022. The development of the VR stroke rehabilitation market is significantly influenced by rehabilitation facilities. For stroke therapy, these facilities offer a controlled setting where patients can get individualized care and attention.
Clinicians are given useful information and insights into the patient's progress through the usage of VR technology in rehabilitation clinics, which enables them to create efficient rehabilitation plans. Also, VR technology enables patients to participate in pleasurable and productive activities that are interactive and engaging compared to more conventional rehabilitation techniques. Better patient outcomes and a rise in demand for VR stroke rehabilitation options are the end results.
There are several key players are there in the fragmented VR stroke rehabilitation sector. To stay ahead of its rivals, they have followed the recent trend of new launches and acquisitions.
Instances of important developmental strategies used among market participants in the VR stroke rehabilitation market are presented below
Similarly, recent developments related to companies coming with the new launches in market which have been tracked by the team at Future Market Insights. These are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2012 to 2022 |
| Historical Data Available for | 2023 to 2033 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, the United kingdom, Germany, Italy, Russia, Spain, France, Benelux, Nordics, Switzerland, India, Thailand, Indonesia, Malaysia, Philippines, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, Egypt, Israel, North Africa and South Africa |
| Key Market Segments Covered | Patient type, Service Provider, and Region |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global VR Stroke Rehabilitation Market created a revenue of around US$ 144.9 billion in 2022.
Adoption of such treatments could be around US$ 376 billion by 2033.
Germany dominates the region and accounted for 7.8% market share in 2022.
Rehabilitation Centers segment held 36.6% of the global market in 2022.
Long-term patients accounted for 69.2% of the total market share in 2022.
1. Executive Summary | VR Stroke Rehabilitation Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Development/Innovation Trends 4. Key Success Factors 4.1. Service Adoption Analysis 4.2. Stroke Prevalence Rate 4.3. Regulatory Landscape 4.4. PESTLE Analysis 4.5. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure 5.1.3. Global Stroke Rehabilitation Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Market Consolidation Activities 5.2.3. Rising Prevalence of Stroke 5.2.4. Availability of Service Modules 5.2.5. Cost of Service 5.2.6. Growing Investment in Healthcare Expenditure 5.2.7. Regulatory Scenario 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Patient Type 6.1.2. By Service Provider 6.1.3. By Region 6.2. 2022 Scenario 7. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022 7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Patient Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Patient Type, 2012 to 2022 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Patient Type, 2023 to 2033 8.3.1. Short Term Patients 8.3.2. Long Term Patients 8.4. Market Attractiveness Analysis By Patient Type 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) By Service Provider, 2012 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Service Provider, 2023 to 2033 9.3.1. Hospitals 9.3.2. Clinics 9.3.3. Rehabilitation Centers 9.3.4. Homecare Settings 9.4. Market Attractiveness Analysis By Service Provider 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region 10.1. Introduction 10.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 11.1. Introduction 11.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033 11.3.1. By Country 11.3.1.1. USA 11.3.1.2. Canada 11.3.2. By Patient Type 11.3.3. By Service Provider 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Patient Type 11.4.3. By Service Provider 11.5. Market Trends 11.6. Key Market Participants - Intensity Mapping 11.7. Drivers and Restraints - Impact Analysis 11.8. Country Level Analysis & Forecast 11.8.1. USA Market Analysis 11.8.1.1. Introduction 11.8.1.2. Market Analysis and Forecast by Market Taxonomy 11.8.1.2.1. By Patient Type 11.8.1.2.2. By Service Provider 11.8.2. Canada Market Analysis 11.8.2.1. Introduction 11.8.2.2. Market Analysis and Forecast by Market Taxonomy 11.8.2.2.1. By Patient Type 11.8.2.2.2. By Service Provider 12. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. Mexico 12.3.1.2. Brazil 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America 12.3.2. By Patient Type 12.3.3. By Service Provider 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Patient Type 12.4.3. By Service Provider 12.5. Market Trends 12.6. Key Market Participants - Intensity Mapping 12.7. Drivers and Restraints - Impact Analysis 12.8. Country Level Analysis & Forecast 12.8.1. Mexico Market Analysis 12.8.1.1. Introduction 12.8.1.2. Market Analysis and Forecast by Market Taxonomy 12.8.1.2.1. By Patient Type 12.8.1.2.2. By Service Provider 12.8.2. Brazil Market Analysis 12.8.2.1. Introduction 12.8.2.2. Market Analysis and Forecast by Market Taxonomy 12.8.2.2.1. By Patient Type 12.8.2.2.2. By Service Provider 12.8.3. Argentina Market Analysis 12.8.3.1. Introduction 12.8.3.2. Market Analysis and Forecast by Market Taxonomy 12.8.3.2.1. By Patient Type 12.8.3.2.2. By Service Provider 13. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. United kingdom 13.3.1.2. Germany 13.3.1.3. France 13.3.1.4. Italy 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Switzerland 13.3.1.9. Nordics 13.3.1.10. Rest of Europe 13.3.2. By Patient Type 13.3.3. By Service Provider 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Patient Type 13.4.3. By Service Provider 13.5. Market Trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country Level Analysis & Forecast 13.8.1. United kingdom Market Analysis 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Patient Type 13.8.1.2.2. By Service Provider 13.8.2. Germany Market Analysis 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Patient Type 13.8.2.2.2. By Service Provider 13.8.3. France Market Analysis 13.8.3.1. Introduction 13.8.3.2. Market Analysis and Forecast by Market Taxonomy 13.8.3.2.1. By Patient Type 13.8.3.2.2. By Service Provider 13.8.4. Italy Market Analysis 13.8.4.1. Introduction 13.8.4.2. Market Analysis and Forecast by Market Taxonomy 13.8.4.2.1. By Patient Type 13.8.4.2.2. By Service Provider 13.8.5. Spain Market Analysis 13.8.5.1. Introduction 13.8.5.2. Market Analysis and Forecast by Market Taxonomy 13.8.5.2.1. By Patient Type 13.8.5.2.2. By Service Provider 13.8.6. BENELUX Market Analysis 13.8.6.1. Introduction 13.8.6.2. Market Analysis and Forecast by Market Taxonomy 13.8.6.2.1. By Patient Type 13.8.6.2.2. By Service Provider 13.8.7. Russia Market Analysis 13.8.7.1. Introduction 13.8.7.2. Market Analysis and Forecast by Market Taxonomy 13.8.7.2.1. By Patient Type 13.8.7.2.2. By Service Provider 13.8.8. Switzerland Market Analysis 13.8.8.1. Introduction 13.8.8.2. Market Analysis and Forecast by Market Taxonomy 13.8.8.2.1. By Patient Type 13.8.8.2.2. By Service Provider 13.8.9. Nordics Market Analysis 13.8.9.1. Introduction 13.8.9.2. Market Analysis and Forecast by Market Taxonomy 13.8.9.2.1. By Patient Type 13.8.9.2.2. By Service Provider 14. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Patient Type 14.3.3. By Service Provider 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Patient Type 14.4.3. By Service Provider 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. China Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Patient Type 14.8.1.2.2. By Service Provider 14.8.2. Japan Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Patient Type 14.8.2.2.2. By Service Provider 14.8.3. South Korea Market Analysis 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Patient Type 14.8.3.2.2. By Service Provider 15. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Malaysia 15.3.1.3. Thailand 15.3.1.4. Indonesia 15.3.1.5. Philippines 15.3.1.6. Rest of South Asia 15.3.2. By Patient Type 15.3.3. By Service Provider 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Patient Type 15.4.3. By Service Provider 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. India Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Patient Type 15.8.1.2.2. By Service Provider 15.8.2. Malaysia Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Patient Type 15.8.2.2.2. By Service Provider 15.8.3. Thailand Market Analysis 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Patient Type 15.8.3.2.2. By Service Provider 15.8.4. Indonesia Market Analysis 15.8.4.1. Introduction 15.8.4.2. Market Analysis and Forecast by Market Taxonomy 15.8.4.2.1. By Patient Type 15.8.4.2.2. By Service Provider 15.8.5. Philippines Market Analysis 15.8.5.1. Introduction 15.8.5.2. Market Analysis and Forecast by Market Taxonomy 15.8.5.2.1. By Patient Type 15.8.5.2.2. By Service Provider 16. Oceania Market 2012 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022 16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Patient Type 16.3.3. By Service Provider 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Patient Type 16.4.3. By Service Provider 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. Australia Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Patient Type 16.8.1.2.2. By Service Provider 16.8.2. New Zealand Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Patient Type 16.8.2.2.2. By Service Provider 17. Middle East and Africa (MEA) Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022 17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Türkiye 17.3.1.3. South Africa 17.3.1.4. Israel 17.3.1.5. North Africa 17.3.1.6. Egypt 17.3.1.7. Rest of Middle East and Africa 17.3.2. By Patient Type 17.3.3. By Service Provider 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Patient Type 17.4.3. By Service Provider 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. GCC Countries Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Patient Type 17.8.1.2.2. By Service Provider 17.8.2. Türkiye Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Patient Type 17.8.2.2.2. By Service Provider 17.8.3. South Africa Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Patient Type 17.8.3.2.2. By Service Provider 17.8.4. Israel Market Analysis 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Patient Type 17.8.4.2.2. By Service Provider 17.8.5. North Africa Market Analysis 17.8.5.1. Introduction 17.8.5.2. Market Analysis and Forecast by Market Taxonomy 17.8.5.2.1. By Patient Type 17.8.5.2.2. By Service Provider 17.8.6. Egypt Market Analysis 17.8.6.1. Introduction 17.8.6.2. Market Analysis and Forecast by Market Taxonomy 17.8.6.2.1. By Patient Type 17.8.6.2.2. By Service Provider 18. Assumptions and Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
VR Stroke Rehabilitation Market
